Literature DB >> 26180390

An unknown cause of hemoptysis-Left anterior descending coronary artery to left upper lobe bronchus fistula.

Yadvir Garg1, Ashok K Rajput1, Calicut M Sreedhar2, Vikas Marwah1.   

Abstract

We report a case of left anterior descending coronary artery to left upper lobe bronchus fistula arising out of the coronary artery aneurysm, secondary to drug eluting balloon angioplasty done for in-stent restenosis in the left anterior descending coronary artery in a 54-year-old male. This is an unreported entity yet.

Entities:  

Keywords:  Aneurysm; drug eluting balloon angioplasty; left anterior descending coronary artery to left upper lobe bronchus fistula

Year:  2015        PMID: 26180390      PMCID: PMC4502205          DOI: 10.4103/0970-2113.159584

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


INTRODUCTION

Coronary artery aneurysm is defined as coronary dilatation, which exceeds the diameter of normal adjacent segments or the diameter of the patient's largest coronary vessel by 1.5 times.[1] Coronary aneurysms represent anomalies identified in 0.15-4.9% of patients undergoing coronary angiography.[1] Aneurysms are observed most commonly in the right coronary artery, and least frequently in the left main coronary artery.[1] Among the causes of coronary artery aneurysm, aneurysms following drug eluting stent implantation has also been described.[2] We present the case of a patient who had infective coronary artery aneurysms that developed after percutaneous intervention (PCI), leading to coronary artery to bronchial fistula and manifested as massive hemoptysis. This entity has never been described in the literature before.

CASE REPORT

A 54-year-old male with history of hypertension initially presented with acute onset chest pain. On evaluation, he was detected to be having critical stenosis in left anterior descending artery (LAD) and left posterior descending artery (LPD) for which drug eluting stenting was done. However, he had a recurrence of angina after 06 months and on subsequent re-evaluation, in-stent restenosis of the LAD was diagnosed. He underwent drug eluting balloon dilatation for the same, but his angina persisted. Subsequently, he started having continuous fever and progressively increasing hemoptysis. There was no cough, pleuritic chest pain, loss of appetite and weight loss. He denied any contact h/o pulmonary tuberculosis. On physical examination he was febrile (temp 102°F), blood pressure was 104/70 mmHg, pulse 90/min, respiratory rate 18 breaths/min. S1, S2 was audible and regular. Rest of the systemic examination was unremarkable. Investigations revealed polymorphonuclear leukcocytosis with neutrophilia. However, biochemical parameters and clotting tests were normal. Blood culture was sterile and D-dimer was negative. Electrocardiography and echocardiography did not reveal any abnormality. On HRCT (Chest) there was patchy consolidation left lingular region. Mantoux test was 5 mm in diameter and there was no AFB on sputum examination. Based on radiological appearance pneumonia was diagnosed presumptively, and he was started on intravenous broad-spectrum antibiotics. However, his symptoms persisted. Fiber optic bronchoscopy revealed mucosal erosion with flap at the entrance of LUL bronchus on the medial aspect, with ongoing bleeding from the site. Blood was trickling down toward lingular segments. However, no endobronchial growth was seen on bronchoscopy [Figure 1].
Figure 1

Fibreoptic bronchoscopy revealed bleeding underneath the mucosal flap at the entrance of LUL bronchus on medial aspect (White arrow)

Fibreoptic bronchoscopy revealed bleeding underneath the mucosal flap at the entrance of LUL bronchus on medial aspect (White arrow) CECT Chest was done, which showed the coronary stent in the position in the left anterior descending and posterior descending arteries. A thick-walled lesion was seen in relation to LAD stent. A post contrast study displayed extravasation of contrast into this soft-tissue density with identifiable communication with LAD [Figure 2a]. These findings were indicative of aneurysm arising from LAD in the vicinity of the stent. There was patchy consolidation in lingular segment abutting mycotic aneurysm suggestive of communication between the aneurysm and lung [Figure 2b].
Figure 2

(a) CECT (Chest)—Mediastinal window showing extravasation of contrast into LAD aneurysm communicating with LAD (White arrow). (b) CECT (Chest)—Parenchymal window aneurysm LAD with consolidation of adjacent lingular segment (Black arrow)

(a) CECT (Chest)—Mediastinal window showing extravasation of contrast into LAD aneurysm communicating with LAD (White arrow). (b) CECT (Chest)—Parenchymal window aneurysm LAD with consolidation of adjacent lingular segment (Black arrow) Coronary angiography [Figure 3] confirmed the findings of CECT chest showing aneurysm involving LAD in the vicinity of stent with normal left circumflex and right coronary arteries and extravasation of contrast. He was taken up for open-heart surgery. Intraoperative findings revealed dense adhesion between proximal LAD, pericardium and adjoining lung. After opening pericardium aneurysm was dissected off the pericardium and left lung. LAD aneurysmectomy, extraction of stents and coronary artery bypass grafting (CABG) with left internal mammary artery (LIMA) to LAD was done. Lung surface was under run to achieve hemostasis. After surgery, the patient improved symptomatically with cessation of hemoptysis and subsidence of fever. Thereafter, he was continued on medical management in the form of dual antiplatelet agents, antianginal and antihypertensive drugs.
Figure 3

Coronary angiogram demonstrating aneurysm in left anterior descending artery (Black arrows)

Coronary angiogram demonstrating aneurysm in left anterior descending artery (Black arrows)

DISCUSSION

Coronary artery aneurysm is most commonly considered to be atherosclerotic in origin.[1] Other causes of coronary artery aneurysm include Kawasaki disease, Percutaneous coronary interventions (PCI), Inflammatory arterial diseases, Systemic lupus erythematosus, Syphilis, Takayasu disease, Chest traumas and Connective tissue disorders. Coronary artery aneurysms after PCI are sporadic (0.3-0.6%) being described in few case reports only.[3] Our patient developed coronary artery aneurysm, as a complication of PCI, which is a rare entity. Coronary artery aneurysm in our patient was further complicated by coronary artery to bronchus fistula leading to hemoptysis. Coronary artery aneurysm complicating into the coronary artery fistula in connection with lung has not been reported yet. Previously coronary artery fistula (post coronary artery aneurysm) has been described in relation to cardiac chambers only.[4] Residual dissection and deep arterial wall injury (rupture or resection of the vessel media) caused by oversized balloons or stents, high-pressure balloon inflations, atherectomy, and laser angioplasty have all been associated with coronary artery aneurysms after coronary intervention.[5] Drug-eluting stents (DES), which locally elute antiproliferative drugs, can dramatically inhibit neo intimal growth, thereby suppressing re-stenosis but at the same time potentially causing coronary aneurysms due to other mechanisms, such as delayed re-endothelialization, inflammatory changes of the medial wall, and hypersensitivity reactions.[5] Coronary infection after stenting can present days to weeks after intervention, most frequently as an acute coronary syndrome,[6] in gross contrast to this, our patient presented with hemoptysis, which has not seen in earlier studies. Our patient had a fistulous connection with left bronchus as the complication of the aneurysm which was quite evident on bronchoscopy, computed tomography and intraoperatively. There was associated consolidation of lingular segments due to trickling down of blood from fistula. Treatment options for coronary aneurysm consist of medical management with the use of antiplatelet and anticoagulation therapy to prevent thrombus formation within the aneurysm.[7] Surgery should be considered for patients with large aneurysms because of the high risk of rupture.[8] Surgical revascularization procedures include saphenous vein grafting alone or in combination with aneurysm resection. Our patient had developed the fistula as a result of the mycotic coronary artery aneurysm for which he underwent LAD aneurysmectomy, extraction of stents and CABG with LIMA to LAD.
  8 in total

1.  Successful treatment of a ruptured mycotic coronary artery aneurysm.

Authors:  M A Osevala; T L Heleotis; B A DeJene
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

Review 2.  Nonsurgical management of left main coronary artery aneurysms: report of 2 cases and review of the literature.

Authors:  Brian Lima; Shalendra K Varma; James E Lowe
Journal:  Tex Heart Inst J       Date:  2006

3.  Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report.

Authors:  Harminder Singh; Charanjit Singh; N Aggarwal; J S Dugal; A Kumar; M Luthra
Journal:  Catheter Cardiovasc Interv       Date:  2005-06       Impact factor: 2.692

4.  Mechanical intervention and coronary artery aneurysm.

Authors:  Shalima R Gautam; Deepak Mishra; B K Goyal
Journal:  J Invasive Cardiol       Date:  2010-12       Impact factor: 2.022

Review 5.  Coronary artery aneurysms after drug-eluting stent implantation.

Authors:  Jiro Aoki; Ajay Kirtane; Martin B Leon; George Dangas
Journal:  JACC Cardiovasc Interv       Date:  2008-02       Impact factor: 11.195

6.  Coronary artery aneurysm: case report.

Authors:  Jeffrey E Everett; Harold M Burkhart
Journal:  J Cardiothorac Surg       Date:  2008-01-24       Impact factor: 1.637

Review 7.  Coronary aneurysms.

Authors:  Aneta I Gziut; Robert J Gil
Journal:  Pol Arch Med Wewn       Date:  2008-12

8.  Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings.

Authors:  Fernando Alfonso; Maria-José Pérez-Vizcayno; Miguel Ruiz; Alfonso Suárez; Miguel Cazares; Rosana Hernández; Javier Escaned; Camino Bañuelos; Pilar Jiménez-Quevedo; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2009-06-02       Impact factor: 24.094

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.